Interleukin 15 primes natural killer cells to kill via NKG2D and cPLA2 and this pathway is active in psoriatic arthritis.
Tang, Fangming; Sally, Benjamin; Ciszewski, Cezary; Abadie, Valerie; Curran, Shane A; Groh, Veronika; Fitzgerald, Oliver; Winchester, Robert J; Jabri, Bana.
; 8(9): e76292, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24086722
Choline metabolite, trimethylamine N-oxide (TMAO), is associated with inflammation in psoriatic arthritis.
The IL-15-AKT-XBP1s signaling pathway contributes to effector functions and survival in human NK cells.
Metabolic control of the scaffold protein TKS5 in tissue-invasive, proinflammatory T cells.
Remission in psoriatic arthritis-where are we now?
The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells.
Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases.
Interleukin (IL)-9/IL-9R axis drives Î³Î´ T cells activation in psoriatic arthritis patients.
An Integrative Approach to Biomarker Development in Psoriatic Arthritis.
Anti-citrullinated protein antibodies are linked to erosive disease in an observational study of patients with psoriatic arthritis.
The Helix-Loop-Helix Protein ID2 Governs NK Cell Fate by Tuning Their Sensitivity to Interleukin-15.